Encoded Therapeutics reports promising early Phase I/II results for its AAV gene therapy developed to treat children with ...

Five-year trial results support chemotherapy de-escalation in HER2-positive breast cancer, with ctDNA offering additional ...

A soft robot could perform real-time imaging, deliver drugs, and take biopsies within the hard-to-reach small intestine.

Genetic differences impact immune cells and may pave the way to new precision medicines for conditions as diverse as multiple ...

Measuring cell-free DNA in blood could help oncologists assess how well CAR T-cell therapy is working for treatment of blood ...

A new AI system from Mayo Clinic finds signs of the most common form of pancreatic cancer much earlier than standard ...

A circular RNA (circRNA) drug enhanced saliva production in radiation-induced xerostomia, a promising development in the ...

NeoCOAST-2 trial finds early ctDNA clearance in blood tests linked to improved lung cancer outcomes, potentially guiding ...

Researchers have developed an AI-powered personal health agent created as an open-source multi-agent framework for dynamic, personalized health interactions.

Phase III findings suggest a promising option for women whose endometrial cancer progresses despite prior chemotherapy and ...

New research links genomic, transcriptomic, and epigenetic features to treatment response in multiple myeloma.

Antibody patterns can signal whether a person will develop inflammatory bowel disease (IBD) up to 10 years before diagnosis.